Updated on December 30th, 2019 by Bob Ciura
The Dividend Aristocrats are some of the best dividend stocks an investor will find. These are companies in the S&P 500 Index, with 25+ consecutive
News
Innovative Industrial Properties Appoints Mary Allis Curran, Former Bank Executive, to its Board of Directors
Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today the
Sunnova Announces Safe Harbor and Convertible Debt Facilities to Fund Increased Growth
Sunnova Energy International Inc. (NYSE: NOVA) today announced that it has closed an aggregate $150 million in financing through an approximately $95 million revolving asset-based loan facility
Navidea Biopharmaceuticals Obtains Partial Dismissal of Claims in New York
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
Franklin Covey to Report First-Quarter Fiscal 2020 Results
Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement, announced today that the conference call to review the Company’s first-quarter fiscal 2020 financial results will
The Foundation Office at Fifth Third Bank Announces Nearly $6.2 Million in 2019 Grants
The Foundation Office at Fifth Third Bank, National Association, has announced gifts of nearly $6.2 million in 2019 through eight major foundations for which it serves as trustee or agent. Grants
Fifth Third Community Development Co. Invests More than $338 Million in 2019
Fifth Third Community Development Co. LLC II, a wholly owned, indirect subsidiary of Fifth Third Bank, National Association, closed more than $338 million in equity investments in 2019. The money
Intevac to Present at 22nd Annual Needham Growth Conference
Intevac, Inc. (Nasdaq: IVAC), a leading supplier of thin-film processing systems and digital night-vision technologies, today announced that company management is scheduled to present at the 22nd
Genesee & Wyoming Announces Completion of Sale to Brookfield Infrastructure and GIC
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) today announced the completion of its previously announced sale to affiliates of Brookfield Infrastructure and GIC.
Under the terms of the sale, each
Wall Street Veteran Blythe Masters Appointed to Phunware Board of Directors
Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, today announced the
Daniel Stone Joins SiteOne Landscape Supply
SiteOne® Landscape Supply, Inc. (NYSE: SITE) announced today that Daniel Stone, Inc. has joined SiteOne. Daniel Stone serves the greater Austin, TX market with a single location focused on the
Lineage Provides Update on Patient Enrollment in Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, today announced additional
Agilent Compliance Services Voted No. 1 in Global Survey
Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey.
Cell
Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Molgradex, an inhaled
TMAC Announces Terry MacGibbon’s Retirement and Board Changes
TMAC Resources Inc. (TSX: TMR) (“TMAC” or the “Company”) today announced changes to the Board of Directors. Terry MacGibbon will retire as Executive Chairman and step down from the Board effective
Dividend Aristocrats In Focus Part 38: McCormick
Updated on December 27th, 2019 by Bob Ciura
In order to become a Dividend Aristocrat, a company must have a strong brand and a dominant industry position.
The Dividend Aristocrats are a group
LSC Communications, Inc. Receives Delisting Notice From the New York Stock Exchange
LSC Communications, Inc. (NYSE: LKSD) (“LSC” or the “Company”) today announced that it received notification from the New York Stock Exchange (the “NYSE”) that the NYSE has determined to commence
Penske Automotive Group (PAG): 3% Dividend Yield, 34 Consecutive Quarters Of Dividend Growth
This is a guest contribution from Shailesh Kumar, founder of Value Stock Guide
Cyclical stocks tend to be shunned by investors when the sector is weak, but this can be precisely the time to
Active Portfolio Management Using Dividend Growth Stocks
Published on December 27th, 2019
This guest contribution series is by Trond K. Odegaard, MBA; CEO at VikingDividendIncome LLC
This is part one of a three-part series discussing portfolio
Opus Bank Announces Fourth Quarter and Year End 2019 Earnings Release and Conference Call Date
Opus Bank (“Opus”) (NASDAQ: OPB) will report its financial results for the fourth quarter and year ending December 31, 2019 before the market opens on Monday, January 27, 2020, and will host a
Opus Bank Announces Appointment of Mary E. “Mimi” Thigpen to Its Board of Directors
Opus Bank (“Opus”) (Nasdaq: OPB) announced today that Mary E. “Mimi” Thigpen has been appointed to Opus’ Board of Directors, effective December 27, 2019, and appointed a member of each of the Audit
MedMen Provides Update on Sale of Non-Core Assets – Designated News Release
MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) (“MedMen” or the “Company”), a leading cannabis retailer with operations across the U.S., today announced the execution of term sheets for
AgeX Therapeutics Announces Drawdown of Second Tranche of Loan Facility from Juvenescence Ltd.
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced the drawdown of a $1.3 million tranche
Novocure to Participate in the 38th Annual J.P. Morgan Healthcare Conference
Novocure (NASDAQ: NVCR) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020, in San Francisco. William Doyle, Novocure’s Executive Chairman, will speak
Murata: Notice of Acquisition of MIRAISENS, a 3DHaptics Company
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) and MIRAISENS, Inc. (head office: Tsukuba City, Ibaraki Prefecture; CEO: Natsuo Koda; hereafter “MIRAISENS”), which offers haptic